149 related articles for article (PubMed ID: 36335976)
21. Integrated prevention of mother-to-child HIV transmission services, antiretroviral therapy initiation, and maternal and infant retention in care in rural north-central Nigeria: a cluster-randomised controlled trial.
Aliyu MH; Blevins M; Audet CM; Kalish M; Gebi UI; Onwujekwe O; Lindegren ML; Shepherd BE; Wester CW; Vermund SH
Lancet HIV; 2016 May; 3(5):e202-11. PubMed ID: 27126487
[TBL] [Abstract][Full Text] [Related]
22. Effect of point-of-care CD4 cell count results on linkage to care and antiretroviral initiation during a home-based HIV testing campaign: a non-blinded, cluster-randomised trial.
Desai MA; Okal DO; Rose CE; Ndivo R; Oyaro B; Otieno FO; Williams T; Chen RT; Zeh C; Samandari T
Lancet HIV; 2017 Sep; 4(9):e393-e401. PubMed ID: 28579225
[TBL] [Abstract][Full Text] [Related]
23. Treatment eligibility and retention in clinical HIV care: A regression discontinuity study in South Africa.
Bor J; Fox MP; Rosen S; Venkataramani A; Tanser F; Pillay D; Bärnighausen T
PLoS Med; 2017 Nov; 14(11):e1002463. PubMed ID: 29182641
[TBL] [Abstract][Full Text] [Related]
24. Integration of postpartum healthcare services for HIV-infected women and their infants in South Africa: A randomised controlled trial.
Myer L; Phillips TK; Zerbe A; Brittain K; Lesosky M; Hsiao NY; Remien RH; Mellins CA; McIntyre JA; Abrams EJ
PLoS Med; 2018 Mar; 15(3):e1002547. PubMed ID: 29601570
[TBL] [Abstract][Full Text] [Related]
25. Financial incentives to promote retention in care and viral suppression in adults with HIV initiating antiretroviral therapy in Tanzania: a three-arm randomised controlled trial.
Fahey CA; Njau PF; Katabaro E; Mfaume RS; Ulenga N; Mwenda N; Bradshaw PT; Dow WH; Padian NS; Jewell NP; McCoy SI
Lancet HIV; 2020 Nov; 7(11):e762-e771. PubMed ID: 32891234
[TBL] [Abstract][Full Text] [Related]
26. Pulmonary effects of immediate versus deferred antiretroviral therapy in HIV-positive individuals: a nested substudy within the multicentre, international, randomised, controlled Strategic Timing of Antiretroviral Treatment (START) trial.
Kunisaki KM; Niewoehner DE; Collins G; Aagaard B; Atako NB; Bakowska E; Clarke A; Corbelli GM; Ekong E; Emery S; Finley EB; Florence E; Infante RM; Kityo CM; Madero JS; Nixon DE; Tedaldi E; Vestbo J; Wood R; Connett JE;
Lancet Respir Med; 2016 Dec; 4(12):980-989. PubMed ID: 27773665
[TBL] [Abstract][Full Text] [Related]
27. Uptake of Home-Based HIV Testing, Linkage to Care, and Community Attitudes about ART in Rural KwaZulu-Natal, South Africa: Descriptive Results from the First Phase of the ANRS 12249 TasP Cluster-Randomised Trial.
Iwuji CC; Orne-Gliemann J; Larmarange J; Okesola N; Tanser F; Thiebaut R; Rekacewicz C; Newell ML; Dabis F;
PLoS Med; 2016 Aug; 13(8):e1002107. PubMed ID: 27504637
[TBL] [Abstract][Full Text] [Related]
28. Cryptococcal meningitis screening and community-based early adherence support in people with advanced HIV infection starting antiretroviral therapy in Tanzania and Zambia: an open-label, randomised controlled trial.
Mfinanga S; Chanda D; Kivuyo SL; Guinness L; Bottomley C; Simms V; Chijoka C; Masasi A; Kimaro G; Ngowi B; Kahwa A; Mwaba P; Harrison TS; Egwaga S; Jaffar S;
Lancet; 2015 May; 385(9983):2173-82. PubMed ID: 25765698
[TBL] [Abstract][Full Text] [Related]
29. Effect of Offering Same-Day ART vs Usual Health Facility Referral During Home-Based HIV Testing on Linkage to Care and Viral Suppression Among Adults With HIV in Lesotho: The CASCADE Randomized Clinical Trial.
Labhardt ND; Ringera I; Lejone TI; Klimkait T; Muhairwe J; Amstutz A; Glass TR
JAMA; 2018 Mar; 319(11):1103-1112. PubMed ID: 29509839
[TBL] [Abstract][Full Text] [Related]
30. Effect of immediate initiation of antiretroviral therapy on risk of severe bacterial infections in HIV-positive people with CD4 cell counts of more than 500 cells per μL: secondary outcome results from a randomised controlled trial.
O'Connor J; Vjecha MJ; Phillips AN; Angus B; Cooper D; Grinsztejn B; Lopardo G; Das S; Wood R; Wilkin A; Klinker H; Kantipong P; Klingman KL; Jilich D; Herieka E; Denning E; Abubakar I; Gordin F; Lundgren JD;
Lancet HIV; 2017 Mar; 4(3):e105-e112. PubMed ID: 28063815
[TBL] [Abstract][Full Text] [Related]
31. Cost-effectiveness of point-of-care testing with task-shifting for HIV care in South Africa: a modelling study.
Sharma M; Mudimu E; Simeon K; Bershteyn A; Dorward J; Violette LR; Akullian A; Abdool Karim SS; Celum C; Garrett N; Drain PK
Lancet HIV; 2021 Apr; 8(4):e216-e224. PubMed ID: 33347810
[TBL] [Abstract][Full Text] [Related]
32. Weekends-off efavirenz-based antiretroviral therapy in HIV-infected children, adolescents, and young adults (BREATHER): a randomised, open-label, non-inferiority, phase 2/3 trial.
BREATHER (PENTA 16) Trial Group
Lancet HIV; 2016 Sep; 3(9):e421-e430. PubMed ID: 27562743
[TBL] [Abstract][Full Text] [Related]
33. Universal test-and-treat in Zambian and South African correctional facilities: a multisite prospective cohort study.
Herce ME; Hoffmann CJ; Fielding K; Topp SM; Hausler H; Chimoyi L; Smith HJ; Chetty-Makkan CM; Mukora R; Tlali M; Olivier AJ; Muyoyeta M; Reid SE; Charalambous S
Lancet HIV; 2020 Dec; 7(12):e807-e816. PubMed ID: 32763152
[TBL] [Abstract][Full Text] [Related]
34. Protocol for a randomised controlled implementation trial of point-of-care viral load testing and task shifting: the Simplifying HIV TREAtment and Monitoring (STREAM) study.
Dorward J; Garrett N; Quame-Amaglo J; Samsunder N; Ngobese H; Ngomane N; Moodley P; Mlisana K; Schaafsma T; Donnell D; Barnabas R; Naidoo K; Abdool Karim S; Celum C; Drain PK
BMJ Open; 2017 Sep; 7(9):e017507. PubMed ID: 28963304
[TBL] [Abstract][Full Text] [Related]
35. Rates of virological failure in patients treated in a home-based versus a facility-based HIV-care model in Jinja, southeast Uganda: a cluster-randomised equivalence trial.
Jaffar S; Amuron B; Foster S; Birungi J; Levin J; Namara G; Nabiryo C; Ndembi N; Kyomuhangi R; Opio A; Bunnell R; Tappero JW; Mermin J; Coutinho A; Grosskurth H;
Lancet; 2009 Dec; 374(9707):2080-2089. PubMed ID: 19939445
[TBL] [Abstract][Full Text] [Related]
36. Universal test and treat is not associated with sub-optimal antiretroviral therapy adherence in rural South Africa: the ANRS 12249 TasP trial.
Iwuji C; McGrath N; Calmy A; Dabis F; Pillay D; Newell ML; Baisley K; Porter K
J Int AIDS Soc; 2018 Jun; 21(6):e25112. PubMed ID: 29890048
[TBL] [Abstract][Full Text] [Related]
37. Two-way mobile phone intervention compared with standard-of-care adherence support after second-line antiretroviral therapy failure: a multinational, randomised controlled trial.
Gross R; Ritz J; Hughes MD; Salata R; Mugyenyi P; Hogg E; Wieclaw L; Godfrey C; Wallis CL; Mellors JW; Mudhune VO; Badal-Faesen S; Grinsztejn B; Collier AC
Lancet Digit Health; 2019 May; 1(1):e26-e34. PubMed ID: 31528850
[TBL] [Abstract][Full Text] [Related]
38. Effect of a differentiated service delivery model on virological failure in adolescents with HIV in Zimbabwe (Zvandiri): a cluster-randomised controlled trial.
Mavhu W; Willis N; Mufuka J; Bernays S; Tshuma M; Mangenah C; Maheswaran H; Mangezi W; Apollo T; Araya R; Weiss HA; Cowan FM
Lancet Glob Health; 2020 Feb; 8(2):e264-e275. PubMed ID: 31924539
[TBL] [Abstract][Full Text] [Related]
39. Improved virological suppression in children on antiretroviral treatment receiving community-based adherence support: a multicentre cohort study from South Africa.
Fatti G; Shaikh N; Eley B; Grimwood A
AIDS Care; 2014 Apr; 26(4):448-53. PubMed ID: 24215157
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of the management of pretreatment HIV drug resistance by oligonucleotide ligation assay: a randomised controlled trial.
Chung MH; McGrath CJ; Beck IA; Levine M; Milne RS; So I; Andersen N; Dross S; Coombs RW; Chohan B; Yatich N; Kiptinness C; Sakr SR; Kiarie JN; Frenkel LM
Lancet HIV; 2020 Feb; 7(2):e104-e112. PubMed ID: 31818716
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
